
HistAI is a company that develops AI-powered digital pathology solutions. Their primary product, HistAI CellDX, is a cloud-based platform designed to facilitate collaborative research and education in pathology. It supports any Whole Slide Image (WSI) file format, offers unlimited collaboration features, task management, and is HIPAA-compliant. HistAI also provides a growing library of AI widgets for streamlining analysis, including segmentation models for skin, colorectal, and thorax tissues, as well as a specialized AI model for melanoma metastasis detection in lymph nodes. The company emphasizes open science and AI innovations, releasing open-source foundation AI models and large datasets like the HISTAI WSI Dataset with 112,000 WSIs. Their business model appears to be SaaS for their platform and potentially licensing or sales of their AI models and datasets.

HistAI is a company that develops AI-powered digital pathology solutions. Their primary product, HistAI CellDX, is a cloud-based platform designed to facilitate collaborative research and education in pathology. It supports any Whole Slide Image (WSI) file format, offers unlimited collaboration features, task management, and is HIPAA-compliant. HistAI also provides a growing library of AI widgets for streamlining analysis, including segmentation models for skin, colorectal, and thorax tissues, as well as a specialized AI model for melanoma metastasis detection in lymph nodes. The company emphasizes open science and AI innovations, releasing open-source foundation AI models and large datasets like the HISTAI WSI Dataset with 112,000 WSIs. Their business model appears to be SaaS for their platform and potentially licensing or sales of their AI models and datasets.
Core product: CellDX cloud platform for whole-slide image (WSI) viewing, annotation, collaboration, and AI widgets
Data assets: Maintains large WSI datasets including the HISTAI WSI Dataset (112,000 WSIs) and a DataHub
Models: Develops pathology foundation and specialized vision models (Hibou family, CellViT-Hibou-L)
Compliance: Claims HIPAA-compliant platform
Founders: Alex Pchelnikov, Ekaterina (Katherine) Ivanova, Dmitry Nechaev
2023
Computational pathology and digital pathology workflows for research, education, and AI development (not for primary diagnosis).
2023
Biotechnology
1,000 USD
Profile records showing $1M raised as of Jan 1, 2025; source summary included a total_funding_amount value of 1000 (currency USD) and last_funding_date 2024-05-09 in provided evidence.